Home » Topics » Conferences

Conferences
RSS

S-2474: antiarthritic agent with dual NSAID/DMARD profile

Dec. 4, 1997

New glucocorticoid from Kissei under development for asthma

Dec. 4, 1997

New inhibitor of inflammatory bone resorption presented at Tokyo congress

Dec. 4, 1997

Anticonvulsant activity demonstrated for adenosine kinase inhibitor

Dec. 3, 1997

Behavioral effects of neurosteroid elucidated in nonhuman primate model

Dec. 3, 1997

Preclinical profile of Co-102862 presented at neuroscience congress

Dec. 3, 1997

ALVAC-IL-12 gene therapy effective in murine model of breast cancer

Dec. 2, 1997

Long-lasting effects on memory impairment of M2 antagonist treatment in rats

Dec. 2, 1997

Potent antiamnesia activity reported for AChE inhibitor DHED

Dec. 2, 1997

Anticonvulsant activity of retigabine established in preclinical model

Dec. 2, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 27, 2026.
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...